ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Clinical Features and Outcomes of Carcinoma of Unknown Primary Site: A single center experience

15th Global Experts Meeting on Pathology and Laboratory Medicine

Suzan. A. Al-Hassanin

Clinical oncology department, Faculty of Medicine, Menoufia University, Shebin Elkom, Egypt

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C2-049

Abstract
Background: Carcinoma of unknown primary (CUP) is a heterogeneous entity of malignant epithelial tumors. In general, CUP follows an aggressive biological and clinical behavior. There is generally limited information regarding this issue. Objectives: To assess clinical and epidemiological features of patients diagnosed with CUP. Patients and method: All patients categorized as having CUP who attended the department of clinical oncology, Menoufia University from January 2013 to December 2015 were included in the study. The patients��? features, investigations and clinical outcomes were collected. Also, time to progression (TTP) and overall survival (OS) were calculated. Results: The study included 103 patients representing about 2.2 % of the total number of patients visited clinical oncology department outpatients��? clinic during the same period. Most of the patients were males, the mean age of the patients was 58 years, pain was the most common presenting symptom, and adenocarcinoma was the most common reported pathological subtype. Only 50.5% of the patients were fit to receive platinum combination chemotherapy. The median TTP was 2 months and the median OS was 3 months. Age, performance status & presenting symptom had statistically significant relation with TTP. While, the baseline performance status, presenting symptoms and pathological subtype had statistically significant relation with OS. Conclusion: Carcinomas of unknown primary origin are not uncommon tumors in clinical oncology department, Menoufia University with wide varieties of clinical presentations. Baseline performance status, presenting symptoms and pathological subtype had statistically significant relation with OS.
Biography
Top